Search research articles
Contact Us
Filters
Showing results (91-100 of 274) with videos related to
Page
of 28
Sort By:
The American Journal of Surgical Pathology
|
March 27, 2018
Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas
Masato Yozu, Melanie E Johncilla, Amitabh Srivastava, et al.
The Oncologist
|
November 22, 2017
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results
Eileen M O'Reilly, James Roach, Paul Miller, et al.
Cancer Chemotherapy and Pharmacology
|
March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
Richard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology
|
February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
Richard Kim, Alexis D Leal, Aparna Parikh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 6, 2020
Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer
Daniel E Lage, Areej El-Jawahri, Charn-Xin Fuh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors
David P Ryan, Joseph P Eder, Thomas Puchlaski, et al.
Investigational New Drugs
|
January 24, 2004
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies
Joseph P Eder, Rocio Garcia-Carbonero, Jeffrey W Clark, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 19, 2005
Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations
Jennifer F Tseng, Christopher G Willett, Carlos Fernandez-del Castillo, et al.
Annals of Surgery
|
January 15, 2005
Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer
Christopher G Willett, Carlos Fernandez Del Castillo, Helen A Shih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2006
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma
Andrew X Zhu, Lawrence S Blaszkowsky, David P Ryan, et al.
Page
of 28
Search research articles
Search
Showing results (91-100 of 274) with videos related to
Sort By:
Page
of 28
The American Journal of Surgical Pathology
|
March 27, 2018
Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas
Masato Yozu, Melanie E Johncilla, Amitabh Srivastava, et al.
The Oncologist
|
November 22, 2017
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results
Eileen M O'Reilly, James Roach, Paul Miller, et al.
Cancer Chemotherapy and Pharmacology
|
March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
Richard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology
|
February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
Richard Kim, Alexis D Leal, Aparna Parikh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 6, 2020
Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer
Daniel E Lage, Areej El-Jawahri, Charn-Xin Fuh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors
David P Ryan, Joseph P Eder, Thomas Puchlaski, et al.
Investigational New Drugs
|
January 24, 2004
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies
Joseph P Eder, Rocio Garcia-Carbonero, Jeffrey W Clark, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 19, 2005
Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations
Jennifer F Tseng, Christopher G Willett, Carlos Fernandez-del Castillo, et al.
Annals of Surgery
|
January 15, 2005
Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer
Christopher G Willett, Carlos Fernandez Del Castillo, Helen A Shih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2006
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma
Andrew X Zhu, Lawrence S Blaszkowsky, David P Ryan, et al.
Page
of 28